KR860000841B1 - 시스프라틴의 안정화된 농축용액의 제조방법 - Google Patents

시스프라틴의 안정화된 농축용액의 제조방법 Download PDF

Info

Publication number
KR860000841B1
KR860000841B1 KR1019810001029A KR810001029A KR860000841B1 KR 860000841 B1 KR860000841 B1 KR 860000841B1 KR 1019810001029 A KR1019810001029 A KR 1019810001029A KR 810001029 A KR810001029 A KR 810001029A KR 860000841 B1 KR860000841 B1 KR 860000841B1
Authority
KR
South Korea
Prior art keywords
cisplatin
solution
polyethylene glycol
platinum
room temperature
Prior art date
Application number
KR1019810001029A
Other languages
English (en)
Korean (ko)
Other versions
KR830004849A (ko
Inventor
아더 카프란 무레이
피터 그라나텍 알폰서
Original Assignee
브리스톨 마이어스 컴페니
도미닉 엠. 메자펠레
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨 마이어스 컴페니, 도미닉 엠. 메자펠레 filed Critical 브리스톨 마이어스 컴페니
Publication of KR830004849A publication Critical patent/KR830004849A/ko
Application granted granted Critical
Publication of KR860000841B1 publication Critical patent/KR860000841B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1019810001029A 1980-03-31 1981-03-28 시스프라틴의 안정화된 농축용액의 제조방법 KR860000841B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US135.373 1980-03-31
US135373 1980-03-31

Publications (2)

Publication Number Publication Date
KR830004849A KR830004849A (ko) 1983-07-20
KR860000841B1 true KR860000841B1 (ko) 1986-07-09

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001029A KR860000841B1 (ko) 1980-03-31 1981-03-28 시스프라틴의 안정화된 농축용액의 제조방법

Country Status (30)

Country Link
JP (1) JPS56152415A (es)
KR (1) KR860000841B1 (es)
AR (1) AR225500A1 (es)
AT (1) AT370996B (es)
AU (1) AU541056B2 (es)
BE (1) BE888209A (es)
CA (1) CA1162479A (es)
CH (1) CH647481A5 (es)
CS (1) CS246051B2 (es)
DD (1) DD157762A5 (es)
DE (1) DE3112272A1 (es)
DK (1) DK158564C (es)
ES (1) ES500869A0 (es)
FI (1) FI70670C (es)
FR (1) FR2480605A1 (es)
GB (1) GB2074028B (es)
GR (1) GR72769B (es)
HU (1) HU183379B (es)
IE (1) IE51070B1 (es)
IL (1) IL62517A (es)
IT (1) IT1170838B (es)
LU (1) LU83270A1 (es)
NL (1) NL8101531A (es)
NO (1) NO156675C (es)
NZ (1) NZ196519A (es)
PH (1) PH17152A (es)
PT (1) PT72774B (es)
SE (1) SE455045B (es)
SU (1) SU1056893A3 (es)
ZA (1) ZA812084B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
IT8148090A0 (it) 1981-03-24
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
JPS56152415A (en) 1981-11-26
NL8101531A (nl) 1981-10-16
ES8206545A1 (es) 1982-08-16
ATA150481A (de) 1982-10-15
NO811081L (no) 1981-10-01
JPS6360008B2 (es) 1988-11-22
IL62517A (en) 1984-01-31
IE810715L (en) 1981-09-30
FI70670B (fi) 1986-06-26
FR2480605A1 (fr) 1981-10-23
CA1162479A (en) 1984-02-21
HU183379B (en) 1984-04-28
AU6816681A (en) 1981-10-08
PT72774A (en) 1981-04-01
DK144281A (da) 1981-10-01
ES500869A0 (es) 1982-08-16
NO156675C (no) 1987-11-04
DE3112272C2 (es) 1990-09-27
FR2480605B1 (es) 1984-05-11
CS246051B2 (en) 1986-10-16
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
NZ196519A (en) 1983-06-17
KR830004849A (ko) 1983-07-20
BE888209A (fr) 1981-09-30
DE3112272A1 (de) 1982-04-29
PT72774B (en) 1982-11-16
DD157762A5 (de) 1982-12-08
SU1056893A3 (ru) 1983-11-23
AT370996B (de) 1983-05-25
GB2074028A (en) 1981-10-28
FI70670C (fi) 1986-10-06
NO156675B (no) 1987-07-27
IE51070B1 (en) 1986-09-17
AR225500A1 (es) 1982-03-31
DK158564C (da) 1990-11-05
AU541056B2 (en) 1984-12-13
GR72769B (es) 1983-12-02
IL62517A0 (en) 1981-05-20
LU83270A1 (fr) 1981-10-29
IT1170838B (it) 1987-06-03
SE8101990L (sv) 1981-11-13
PH17152A (en) 1984-06-13
DK158564B (da) 1990-06-11

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
US4322391A (en) Process for the preparation of microcrystalline cisplatin
JP3547755B2 (ja) オキサリプラティヌムの医薬的に安定な製剤
FI78236B (fi) Foerfarande foer framstaellning av en frystorkad doseringsenhet av cis-platina (ii) diamindiklorid.
KR100351713B1 (ko) 백금(ii) 항종양제의 안정용액
FI90204B (fi) Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi
JPH0611700B2 (ja) アントラサイクリングリコシド含有薬学的組成物
KR860000841B1 (ko) 시스프라틴의 안정화된 농축용액의 제조방법
FI66121B (fi) Foerfarande foer framstaellning av en stabil vattenloesning avisplatin
DK159376B (da) Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid
PT93991B (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
JPH01305030A (ja) トラコーマクラミジア感染症の単一筋肉内投与による治療用の組成物
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
US6818662B2 (en) Pharmaceutical composition
US6060498A (en) Composition containing antitumor agent
AU623632B2 (en) A solution of carboplatin
JPS63174927A (ja) 抗菌性凍結乾燥製剤
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
KR830000525B1 (ko) 주사용 아세틸 살리실레이트 분말제의 안정화 방법
KR950010149B1 (ko) 5-클로로-1-[1-{3-(2,3-디하이드로-2-옥소-1h-벤즈이미다졸-1-열)프로필}-4-피페리딘]-1,3-디하이드로-2h-벤즈이미다졸-2-온(돔페리돈) 액제의 제조방법
JPS63174928A (ja) 注射用製剤
JPS5896015A (ja) 注射用ネオスラマイシンの製造法
CZ228896A3 (cs) Protinádorový léčebný přípravek na bázi karboplatiny a způsob jeho výroby
SK418391A3 (en) Antitumor therapeutical preparation based on carboplatinum and process for preparing thereof